DNA hypomethylation upregulates expression of the MGAT3 gene in HepG2 cells and leads to changes in N-glycosylation of secreted glycoproteins

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Klasić, Marija ^a   Krištić, Jasminka ^b   Korać, Petra ^a   Horvat, Tomislav ^a   Markulin, Dora ^a   Vojta, Aleksandar ^a   Reiding, Karli R ^c   Wuhrer, Manfred ^c,d   Lauc, Gordan ^b,e   Zoldoš, Vlatka ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA-1,4-MANNOSYL-GLYCOPROTEIN BETA-1,4-N-ACETYLGLUCOSAMINYLTRANSFERASE; GLYCOPROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE;

DNA METHYLATION; GENE EXPRESSION; GENETICS; GLYCOSYLATION; HEP-G2 CELL LINE; HUMAN; METABOLISM; UPREGULATION;

DNA METHYLATION; GENE EXPRESSION; GLYCOPROTEINS; GLYCOSYLATION; HEP G2 CELLS; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; UP-REGULATION;

EID: 84969862364     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24363     Document Type: Article

References (52)

1. Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. & Dwek, R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 3343, 1235681-1-1235681-8 (2014).
2. Moremen, K. W., Tiemeyer, M. & Nairn, A. V. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13, 448-462 (2012).
3. Marth, J. D. A unified vision of the building blocks of life. Nat. Cell Biol. 10, 1015-1016 (2008).
4. Zoldoš, V., Novokmet, M., Beceheli, I. & Lauc, G. Genomics and epigenomics of human glycome. Glycoconj. J. 30, 41-50 (2013).
5. Krištić, J., Zoldoš, V. & Lauc, G. Complex genetics of protein glycosylation In Glycoscience: Biology and Medicine (eds Taniguchi, N., Endo, T., Hart, G. W., Seeberger, P. H. & Wong, C. H.) Ch. 8, 1303-1310 (Springer Japan, 2015).
6. Nairn, A. V. et al. Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J. Biol. Chem. 283, 17298-17313 (2008).
7. Yamamoto-Hino, M. et al. Identification of genes required for neural-specific glycosylation using functional genomics. PLos Genet. 6, e1001254 (2010).
8. Lauc, G. et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLos Genet. 9, e1003225 (2013).
9. Menni, C. et al. Glycosylation of immunoglobulin G: role of genetic and epigenetic influences. PLos One 8, e82558 (2013).
10. Knežević, A. et al. Variability, heritability and environmental determinants of human plasma N-glycome. J. Proteome Res. 8, 694-701 (2009).
11. Knežević, A. et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 20, 959-969 (2010).
12. Walt, D. et al. Transforming Glycoscience: A Roadmap for the Future. Ch. 3, 37-55 (The Nacional Academies Press, 2012).
13. Stowell, S. R., Ju, T. & Cummings, R. D. Protein glycosylation in cancer. Annu. Rev. Pathol. 10, 473-510 (2015).
14. Maverakis, E. et al. Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J. Autoimmun. 57, 1-13 (2015).
15. Horvat, T., Zoldoš, V. & Lauc, G. Evolutional and clinical implications of epigenetic regulation of protein glycosylation. Clin. Epigenetics 2, 425-432 (2011).
16. Tsuboi, S., Hatakeyama, S., Ohyama, C. & Fukuda, M. Two opposing roles of O-glycans in tumor metastasis. Trends Mol. Med. 18, 224-232 (2012).
17. Pucic, M. et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell Proteomics 10, M111. 010090 (2011).
18. Gornik, O. et al. Stability of N-glycan profiles in human plasma. Glycobiology 19, 1547-1553 (2009).
19. Novokmet, M. et al. Changes in IgG and total plasma protein glycomes in acute systemic inflammation. Sci. Rep. 4, 4347, doi: 10.1038 (2014).
20. Ladd-Acosta, C. & Fallin M. D. The role of epigenetics in genetic and environmental epidemiology. Epigenomics, doi: 10.2217/ epi.15.102 (2015).
21. Lauc, G., Vojta, A. & Zoldoš, V. Epigenetic regulation of glycosylation is quantum mechanics of biology. Biochim. Biophys. Acta 1840, 65-70 (2014).
22. Horvat, T., Mužinić, A., Barišić, D., Herak-Bosnar, M. & Zoldoš, V. Epigenetic modulation of HeLa cell membrane N-glycome. Biochim. Biophys. Acta 1820, 1412-1419 (2012).
23. Horvat, T. et al. Reversibility of membrane N-glycome of HeLa cells upon treatment with epigenetic inhibitors. PLos ONE 8, e54672 (2013).
24. Anugraham, M. et al. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status. Mol. Cell Proteomics 13, 2213-2232 (2014).
25. Saldova, R. et al. 5-AZA-2′-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics 6, 1362-1372 (2011).
26. Pedersen, M. E. et al. An epidermal microRNA regulates neuronal migration through control of the cellular glycosylation state. Science 341, 1404-1408 (2013).
27. Bernardi, C., Soffientini, U., Piacente, F. & Tonetti, M. G. Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells. PLos ONE 8, e76540 (2013).
28. Agrawal, P. et al. Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode. Proc. Natl. Acad. Sci. USA 111, 4338-4343 (2014).
29. Kim, Y. S. & Deng, G. Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation. Gastroenterology 135, 305-309 (2008).
30. Pinho, S. S. et al. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim. Biophys. Acta 1830, 2690-2700 (2013).
31. Takahashi, M., Kuroki, Y., Ohtsubo, K. & Taniguchi, N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr. Res. 344, 1387-1390 (2009).
32. Kamiyama, T. et al. Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis. Hepatology 57, 2314-2325 (2013).
33. An, H. J. et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J. Proteome Res. 5, 1626-1635 (2006).
34. Kirmiz, C. et al. A serum glycomics approach to breast cancer biomarkers. Mol. Cell Proteomics 6, 43-55 (2007).
35. Chen, C. Y. et al. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc. Natl. Acad. Sci. USA 110, 630-635 (2013).
36. Yoshimura, M., Nishikawa, A., Ihara, Y., Taniguchi, S. & Taniguchi, N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl. Acad. Sci. USA 92, 8754-8758 (1995).
37. Ohtsubo, K., Chen, M. Z., Olefsky, J. M. & Marth, J. D. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat. Med. 17, 1067-1075 (2011).
38. Karahoca, M. & Momparler, R. L. Pharmacokinetic and pharmacodynamic analysis of 5-aza-2′-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin Epigenetics 5, 3 (2013).
39. Nieto, M. et al. The absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine. Oncogene 23, 735-743 (2004).
40. Zoldos, V. et al. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome. Epigenetics 7, 164-172 (2012).
41. Orr, S. L. et al. A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins. Glycobiology 23, 363-380 (2013).
42. Kurimoto, A. et al. The absence of core fucose up-regulates Gnt-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function. J. Biol. Chem. 289, 11704-11714 (2014).
43. Takamatsu, S. et al. Physiological and glycomic characterization of N-acetylglucosaminyltransferase-IVa and-IVb double deficient mice. Glycobiology 20, 485-497 (2010).
44. Vojta, A., Samarzija, I., Bockor, L. & Zoldos, V. Glyco-genes change expression in cancer through aberrant methylation. BBA Gen Subjects, doi: 10.1016/j.bbagen.2016.01.002.
45. Ihara, Y. et al. Ectopic expression of N-acetylglucosaminyltrasferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. Proc. Natl. Acad. Sci. USA 95, 2526-2530 (1998).
46. Koyota, S. et al. Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc. J. Biol. Chem. 276, 32867-32874 (2001).
47. Block, T. M. et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc. Natl. Acad. Sci. USA 102, 779-784 (2005).
48. Miyahara, K. et al. Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with Sorafenib. Hepatology 59, 355-356 (2014).
49. Liu, T. et al. The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis. PLos ONE 9, e107941 (2014).
50. Zhao, Y. et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275, 1939-1948 (2008).
51. Kagey, J. D., Kapoor-Vazirani, P., McCabe, M. T., Powell, D. R. & Vertino, P. M. Long-term stability of demethylation after transient exposure to 5-aza-2′-deoxycytidine correlates with sustained RNA polymerase II occupancy. Mol. Cancer Res. 8, 1048-1059 (2010).
52. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-5, doi: 10.1093/nar/ gks1193 (2013).